These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22305303)

  • 1. The classical dichotomy between presentation of endogenous antigens via the MHC class I pathway and exogenous antigens via the MHC class-II pathway.
    Kyewski B; Haskins K
    Curr Opin Immunol; 2012 Feb; 24(1):67-70. PubMed ID: 22305303
    [No Abstract]   [Full Text] [Related]  

  • 2. Alternative pathways for MHC class I presentation: a new function for autophagy.
    Chemali M; Radtke K; Desjardins M; English L
    Cell Mol Life Sci; 2011 May; 68(9):1533-41. PubMed ID: 21390546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathways.
    Loss GE; Elias CG; Fields PE; Ribaudo RK; McKisic M; Sant AJ
    J Exp Med; 1993 Jul; 178(1):73-85. PubMed ID: 8315396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation.
    Li Y; Ke Y; Gottlieb PD; Kapp JA
    J Leukoc Biol; 1994 Nov; 56(5):616-24. PubMed ID: 7525819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The function of the invariant chain in antigen presentation by MHC class II molecules.
    Hämmerling GJ; Moreno J
    Immunol Today; 1990 Oct; 11(10):337-40. PubMed ID: 1977405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class II MHC molecules can use the endogenous pathway of antigen presentation.
    Nuchtern JG; Biddison WE; Klausner RD
    Nature; 1990 Jan; 343(6253):74-6. PubMed ID: 1967486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing and presentation of endocytically acquired protein antigens by MHC class II and class I molecules.
    German RN; Castellino F; Han R; Reis e Sousa C; Romagnoli P; Sadegh-Nasseri S; Zhong GM
    Immunol Rev; 1996 Jun; 151():5-30. PubMed ID: 8872483
    [No Abstract]   [Full Text] [Related]  

  • 8. The dichotomy of peptide presentation by class I and class II MHC proteins.
    Urban RG; Chicz RM; Vignali DA; Strominger JL
    Chem Immunol; 1993; 57():197-234. PubMed ID: 8260088
    [No Abstract]   [Full Text] [Related]  

  • 9. Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines.
    Kovacsovics-Bankowski M; Rock KL
    Eur J Immunol; 1994 Oct; 24(10):2421-8. PubMed ID: 7925570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas exotoxin-mediated delivery of exogenous antigens to MHC class I and class II processing pathways.
    Lippolis JD; Denis-Mize KS; Brinckerhoff LH; Slingluff CL; Galloway DR; Engelhard VH
    Cell Immunol; 2000 Aug; 203(2):75-83. PubMed ID: 11006005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding and modulating the MR1 metabolite antigen presentation pathway.
    McWilliam HEG; Salio M
    Mol Immunol; 2021 Jan; 129():121-126. PubMed ID: 33293099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial modulation of antigen processing and presentation.
    Maksymowych WP; Kane KP
    Microbes Infect; 2000 Feb; 2(2):199-211. PubMed ID: 10742692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-dressing: an alternative mechanism for antigen presentation.
    Campana S; De Pasquale C; Carrega P; Ferlazzo G; Bonaccorsi I
    Immunol Lett; 2015 Dec; 168(2):349-54. PubMed ID: 26551033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Antigen Processing and Presentation Machinery in Lymphatic Endothelial Cells.
    Santambrogio L; Berendam SJ; Engelhard VH
    Front Immunol; 2019; 10():1033. PubMed ID: 31134089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC presentation via autophagy and how viruses escape from it.
    Gannage M; Münz C
    Semin Immunopathol; 2010 Dec; 32(4):373-81. PubMed ID: 20857294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in MHC class I molecules influence their interactions with components of the antigen processing and presentation pathway.
    Aflalo A; Boyle LH
    Int J Immunogenet; 2021 Aug; 48(4):317-325. PubMed ID: 34176210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a systems understanding of MHC class I and MHC class II antigen presentation.
    Neefjes J; Jongsma ML; Paul P; Bakke O
    Nat Rev Immunol; 2011 Nov; 11(12):823-36. PubMed ID: 22076556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy and its role in MHC-mediated antigen presentation.
    Crotzer VL; Blum JS
    J Immunol; 2009 Mar; 182(6):3335-41. PubMed ID: 19265109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy.
    Ma W; Smith T; Bogin V; Zhang Y; Ozkan C; Ozkan M; Hayden M; Schroter S; Carrier E; Messmer D; Kumar V; Minev B
    J Transl Med; 2011 Mar; 9():34. PubMed ID: 21450109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.